Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis

Hepatology. 2018 Jul;68(1):7-9. doi: 10.1002/hep.29776. Epub 2018 May 10.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Computer Simulation
  • Humans
  • Liver Cirrhosis
  • Liver Neoplasms*
  • Mass Screening